This Study is Two-center, Prospective, Randomized, Open-label, Controlled, Investigator-sponsored Study That Aims to Investigate the Efficacy of Low-dose Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Minor-to-moderate Ischemic Stroke During Hospitalization

Conditions: Ischemic Stroke Interventions: Drug: Colchicine; Drug: Clopidogrel Sponsors: Mikhail Zykov Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials